Clinical Trials Browser

Phase 1 × (225)Ac-PSMA-617 × 90 days × Clear all

Genital Diseases, Male, Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT07054346 2026-04-01

LUTACT

Phase 1 Recruiting

45 enrolled

Genitourinary

Disease, Prostatic Neoplasms

Clinical Trials

Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer

LUTACT